Juvenile Idiopathic Arthritis (jia) Clinical Trials
3 recruiting trials for Juvenile Idiopathic Arthritis (jia). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Juvenile Idiopathic Arthritis (jia) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 4 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Children's Hospital Medical Center, Cincinnati (1), University of Sao Paulo General Hospital (1), Oregon Health and Science University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Not applicable- observational study (other, 1 trial), followed by Dengue 1,2,3,4 (attenuated) vaccine.
Track Juvenile Idiopathic Arthritis (jia) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The BRIDGE Pain Study
The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how...
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in...
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Juvenile Idiopathic Arthritis (jia), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Juvenile Idiopathic Arthritis (jia), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Juvenile Idiopathic Arthritis (jia), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.